New hope for kids with rare swelling disorder: early access drug available
Disease control
AVAILABLE
This program provides early access to an investigational drug called sebetralstat for children aged 2 to 11 with hereditary angioedema (HAE). HAE causes sudden, painful swelling attacks. The drug is taken at the time of an attack to help control symptoms. The program is for child…
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated May 17, 2026 10:39 UTC